Advertisement

Topics

Incyte Raises Awareness for Myeloproliferative Neoplasms as Part of Rare Disease Day 2017

09:00 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
February 28, 2017, commemorates the tenth annual Rare Disease Day Incyte supports efforts to raise awareness and improve diagnosis and treatment for the nearly 200,000 people in the United States with MPNs, a group of...

Other Sources for this Article

Incyte Corporation
Catalina Loveman, +1 302-498-6171
cloveman@incyte.com

NEXT ARTICLE

More From BioPortfolio on "Incyte Raises Awareness for Myeloproliferative Neoplasms as Part of Rare Disease Day 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...